Related Experiment Videos

Transporters and the blood-brain barrier (BBB)

A B De Boer¹, E L De Lange, I C Van der Sandt

¹Division of Pharmacology, Leiden/Amsterdam Center for Drug Research, University of Leiden, The Netherlands.

International Journal of Clinical Pharmacology and Therapeutics

|February 26, 1998

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Avoidance of "first-pass" elimination of rectally administered propranolol in relation to the site of absorption in rats.

Pharmaceutical research·2013

Site specific rectal drug administration in man with an osmotic system: influence on "first-pass" elimination of lidocaine.

Pharmaceutical research·2013

Correlation between in vivo antipyrine metabolite formation and theophylline metabolism in rats.

Pharmaceutical research·2013

Evidence of P-glycoprotein mediated apical to basolateral transport of flunisolide in human broncho-tracheal epithelial cells (Calu-3).

British journal of pharmacology·2001

P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier.

Pharmaceutical research·2001

Active efflux of the 5-HT(1A) receptor agonist flesinoxan via P-glycoprotein at the blood-brain barrier.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2001

See all related articles